Zuberi 2Mg Bottle Of 25 Bottles

• Chronic lymphatic (lymphocytic) leukemia (CLL)
• Malignant lymphomas, including lymphosarcoma, Giant follicular lymphoma, and Hodgkin's disease

• If you are allergic to the medicine.
• If your disease has previously shown resistance to chlorambucil.

• Bone marrow suppression, which may cause low white blood cell, red blood cell, or platelet counts.

• Gastrointestinal disturbances: nausea and vomiting, diarrhea, and oral ulceration (reported to occur infrequently).
• Skin reactions, including rash
• Anaemia
• Secondary blood cancers, particularly after long-term treatment

• Severe or prolonged bone marrow suppression, including pancytopenia
• Severe infections or fever
• Unusual bleeding or bruising
• Seizures, confusion, agitation, ataxia, or hallucinations
• Severe skin reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis
• Pulmonary fibrosis or interstitial pneumonia
• Hepatotoxicity and jaundice
• Infertility, which may be reversible or permanent
• Secondary malignancies, including leukemia

Other General Warnings

• You notice signs of infertility or amenorrhea.
• You develop a skin rash, particularly if it is severe or accompanied by other symptoms.
• You notice unusual lumps or masses or develop a persistent cough.
• You develop jaundice or yellowing of the skin or eyes.
• You develop fever, unusual bleeding, or bruising.
• You experience seizures, confusion, agitation, or problems with coordination.

• Always take this medicine as prescribed by your doctor. Take the tablet daily on an empty stomach, at least 1 hour before meals or 3 hours after meals.
• Do not break, chew, or crush the tablet. Swallow the whole tablet with water. Do not change the dose or treatment schedule without medical advice.

• Never take Zuberi tablet without ongoing medical supervision.
• Attend regular blood tests as advised by your doctor to monitor blood counts.
• Contact your doctor promptly if you notice a skin rash, unusual bleeding, fever, jaundice, persistent cough, seizures, nausea, vomiting, amenorrhea, or unusual lumps/masses.
• Women of childbearing potential should be advised to avoid becoming pregnant during treatment.
• Tell your doctor about any recent radiation therapy or chemotherapy, since full-dose Zuberi tablet should generally be avoided within 4 weeks of these treatments.
• Use caution when driving or operating machinery if you experience tremors, confusion, agitation, or ataxia.
• Store tablets in the refrigerator (2° to 8°C / 36° to 46°F) with the child-resistant closure in place.

Overdose

Missed a Dose

Interactions with other medicines

• Inform your doctor about all prescription medicines, over-the-counter medicines, supplements, and herbal products you take.
• Live vaccines are not recommended during treatment because of the risk of infection in immunocompromised patients. Medicines such as fludarabine, pentostatin, and cladribine may increase chlorambucil's cytotoxic effects.
• Tell your doctor if you have recently received chemotherapy or radiation therapy, as this may affect blood counts and treatment planning.

Interactions with food items